AMN:NYE-AMN Healthcare Services, Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 93.85

Change

-1.40 (-1.47)%

Market Cap

USD 4.53B

Volume

0.34M

Average Target Price

USD 91.29 (-2.73%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. The company operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing under the American Mobile, Onward Healthcare, and O'Grady Peyton brands; rapid response nurse staffing and labor disruption services under the NurseChoice and HealthSource Global Staffing brands; local or per diem staffing services under Nursefinders brand; and locum tenens staffing services under the Staff Care and Locum Leaders brands. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists under the Med Travelers and Club Staffing brands; revenue cycle solutions; physician permanent placement services to hospitals, healthcare facilities, and physician practice groups; interim leadership staffing and executive search services; and recruitment process outsourcing services. In addition, it offers managed services programs; language interpretation services; vendor management systems; workforce optimization services; credentialing services; digital staffing services; and flex pool management services. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Taxas.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-18 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Healthcare, Inc

-5.85 (-2.82%)

USD68.52B 15.48 9.22
FMS Fresenius Medical Care AG & Co..

-0.41 (-0.98%)

USD20.32B 15.47 9.64
OSH Oak Street Health, Inc

-0.38 (-0.67%)

USD13.56B N/A N/A
UHS Universal Health Services, Inc

-5.17 (-3.40%)

USD13.15B 12.88 8.40
DVA DaVita Inc

-1.98 (-1.60%)

USD13.13B 17.56 10.78
EHC Encompass Health Corporation

-1.02 (-1.26%)

USD8.04B 26.51 12.37
CHE Chemed Corporation

-2.71 (-0.57%)

USD7.64B 23.50 15.85
THC Tenet Healthcare Corporation

-2.70 (-3.93%)

USD7.33B 18.21 7.43
SEM Select Medical Holdings Corpor..

-1.44 (-3.41%)

USD5.70B 17.85 10.69
MD MEDNAX, Inc

-0.87 (-2.76%)

USD2.72B 9.15 22.24

ETFs Containing AMN

Symbol Name Weight Mer Price(Change) Market Cap
ETHO Etho Climate Leadership U.. 0.00 % 0.48 %

-0.84 (-1.41%)

USD0.16B
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

-3.75 (-1.94%)

USD0.51B
XHS SPDR S&P Health Care Serv.. 0.00 % 0.35 %

-2.29 (-2.00%)

USD0.15B
HERS:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

USD3.37M
HERS-B:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.51% 67% D+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.51% 67% D+ 87% B+
Trailing 12 Months  
Capital Gain 115.25% 67% D+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 115.25% 67% D+ 90% A-
Trailing 5 Years  
Capital Gain 145.23% 75% C 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 145.23% 75% C 85% B
Average Annual (5 Year Horizon)  
Capital Gain 18.14% 62% D- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.14% 57% F 79% C+
Risk Return Profile  
Volatility (Standard Deviation) 27.85% 76% C 39% F
Risk Adjusted Return 65.15% 86% B 75% C
Market Capitalization 4.53B 59% F 71% C-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 40.33 16% F 19% F
Price/Book Ratio 5.11 47% F 20% F
Price / Cash Flow Ratio 17.63 5% F 27% F
EV/EBITDA 17.37 40% F 38% F
Management Effectiveness  
Return on Equity 1,558.94% 95% A 95% A
Return on Invested Capital 8.46% 64% D 70% C-
Return on Assets 5.54% 73% C 80% B-
Debt to Equity Ratio 104.67% 53% F 35% F
Technical Ratios  
Short Ratio 2.34 59% F 48% F
Short Percent 1.87% 77% C+ 64% D
Beta 0.40 86% B 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector